Acute tubulointerstitial nephritis associated with infliximab therapy in a patient with Crohn’s disease: a case report

2Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report the case of a 39-year-old man who presented with a history of generalized fatigue, nausea, subjective fever with rigors, and renal dysfunction after receiving infliximab (IFX) therapy for Crohn’s disease. A renal biopsy revealed acute tubulointerstitial nephritis (ATIN). After other causes of acute kidney injury were excluded, steroid therapy was initiated, his fever subsided, and kidney function improved. From this case report, infliximab could be a rare cause of elevated kidney function and that it should be not considered a completely safe treatment or disregarded as potential cause of ATIN.

Cite

CITATION STYLE

APA

Alghamdi, N., Alshehri, F., Alhazza, S., Bhutto, F., Alhassan, A., Kechrid, M., … Alahmadi, Y. (2025). Acute tubulointerstitial nephritis associated with infliximab therapy in a patient with Crohn’s disease: a case report. CEN Case Reports, 14(2), 266–270. https://doi.org/10.1007/s13730-024-00943-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free